Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire

Immunosuppressive treatment is a current practice in MS therapy. Mitoxantrone has gained largest acceptance. Differences in clinical indications of mitoxantrone, cyclophosphamide, azathioprine and methotrexate are described.